Aclidinium/Formoterol

Alternative Names: Duaklir Pressair

Aclidinium/Formoterol is a combination inhaler used as maintenance treatment for COPD. It contains two long-acting bronchodilators: aclidinium, a LAMA that relaxes airway muscles by blocking muscarinic receptors, and formoterol, a LABA that opens airways by stimulating beta2 receptors. Together, they improve lung function, reduce shortness of breath, and help prevent exacerbations. This medication is taken twice daily using the Pressair inhaler device. Common side effects include headache, cough, and sore throat, and it is not intended for sudden breathing problems or asthma treatment.

Treatment Type: Prescription Medication

Treatment Class: Beta Agonist

Treatment Modality: N/A

Aclidinium/Formoterol

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Based on the review, Aclidinium/Formoterol appears to be an effective maintenance therapy for moderate to severe COPD patients who require dual bronchodilation. The medication is particularly recommended for those with persistent symptoms or frequent exacerbations that are not adequately controlled by single-drug treatments. With a generic version available, it also offers a cost-effective treatment option.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
3.0
1 = Very Expensive 5 = Very Affordable

3.0

Moderate Cost
Relief Speed
3.0
1 = No Relief 5 = Immediate Relief

3.0

Moderate Relief
Side Effects
4.0
1 = Intolerable Effect 5 = No Effect

4.0

Mild Effect
Treatment Line
3.0
1 = Third-line or more 5 = First-line

3.0

Second Line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews
5
0%
4
100%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review, Aclidinium/Formoterol appears to be an effective maintenance therapy for moderate to severe COPD patients who require dual bronchodilation. The medication is particularly recommended for those with persistent symptoms or frequent exacerbations that are not adequately controlled by single-drug treatments. With a generic version available, it also offers a cost-effective treatment option.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
2 months ago
Aclidinium/Formoterol is a combination inhaler used for COPD that contains a long-acting muscarinic antagonist and a long-acting beta-agonist, helping relax airway muscles and improve airflow. I typically consider it a second-line option when symptoms aren’t adequately controlled with a single long-acting inhaler. The dual mechanism can provide better symptom control and reduce shortness of breath for many patients. One downside is that there is no generic version available, and similar medication combinations can often be prescribed using other inhalers at a lower cost.
#ModerateCost #ModerateRelief #MildEffect #Second-line #Maintenance
View Professional Disclosures

Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All